Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ruxolitinib cream in Hidradenitis Suppurativa
NCT05635838Phase 2Completed
- Sponsor
- Incyte
- Start
- Dec 2022
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of ruxolitinib cream in hidradenitis suppurativa (HS), sponsored by Incyte. Started Dec 2022; status: completed.
02
Drugs
ruxolitinib cream
03
Conditions
hidradenitis suppurativa (HS)
Beyond the preview
Go deeper on NCT05635838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05635838.